Who are ResMed's decision-makers?
ResMed is led by Mick Farrell. Sellers should map decisions across the executive sponsor, business-unit owner, procurement, legal, security, compliance, finance, and operational stakeholders.
- CEO
- Mick Farrell
- CFO/key exec
- Brett Sandercock
- Founded
- 1989
- Employees
- 11,000+
- HQ
- San Diego, CA
- Status
- NYSE: RMD
- Mick FarrellChairman and Chief Executive OfficerCEO since 2013Leads ResMed's connected sleep, respiratory, and SaaS strategy.
- Brett SandercockChief Financial OfficerCFO since 2006Finance leader through ResMed's global device and SaaS expansion.
- Lucile BlaisePresident, Sleep and Respiratory CareSenior executive leadershipCommercial leader for core device and mask growth.
- Raj SodhiPresident, SaaSSenior executive leadershipLeads residential-care software and digital health platforms.
Who leads ResMed?
ResMed's leadership team combines enterprise healthcare operations, finance, clinical, product, technology, legal, and commercial roles. The CEO and CFO set capital priorities, while business-unit leaders decide which operational problems become funded initiatives.
Who actually makes buying decisions at ResMed?
Buying decisions usually start with a business-unit sponsor, then move through procurement, finance, legal, data-security, compliance, privacy, and implementation owners. Clinical, reimbursement, or quality stakeholders become essential whenever the purchase touches patient care, regulated data, medical products, or payer/provider economics.
How is ResMed organized as it scales?
ResMed operates through business units tied to Sleep and breathing health devices, masks, accessories, and residential-care software. That creates multiple entry points, but enterprise standards for security, compliance, contracting, and vendor management can still control the final approval path.
As of June 2026.Sources:ResMed leadershipResMed annual reports
ResMed — frequently asked questions
